{"name":"Amifampridine","desc":"Amifampridine (pyridine-3,4-diamine, 3,4-diaminopyridine, 3,4-DAP) is used as a drug, predominantly in the treatment of a number of rare muscle diseases. The free base form of the drug has been used to treat congenital myasthenic syndromes and Lambertâ€“Eaton myasthenic syndrome (LEMS) through compassionate use programs since the 1990s and was recommended as a first line treatment for LEMS in 2006, using ad hoc forms of the drug, since there was no marketed form.","images":[{"alt":"Diaminopyridine.png","src":"//upload.wikimedia.org/wikipedia/commons/thumb/b/b1/Diaminopyridine.png/120px-Diaminopyridine.png"},{"alt":"3,4-diaminopyridine-3D-balls.png","src":"//upload.wikimedia.org/wikipedia/commons/thumb/1/1b/3%2C4-diaminopyridine-3D-balls.png/120px-3%2C4-diaminopyridine-3D-balls.png"}],"link":"/wiki/3,4-diaminopyridine"}